Quotes 5-day view Delayed Nyse
01/14/2021
01/15/2021
01/19/2021
01/20/2021
01/21/2021
Date
44.65(c)
43.71(c)
43.47(c)
43.27(c)
43.42(c)
Last
2 470 582
2 426 233
1 217 268
1 205 413
1 315 634
Volume
-3.19% -2.11% -0.55% -0.46% +0.35% Change
Sales 2020
5 119 M - -
Net income 2020
65,6 M - -
Net Debt 2020
2 747 M - -
P/E ratio 2020
63,9x
Yield 2020
2,06%
Sales 2021
5 198 M - -
Net income 2021
296 M - -
Net Debt 2021
2 247 M - -
P/E ratio 2021
25,1x
Yield 2021
2,23%
Capitalization
5 926 M 5 926 M -
EV / Sales 2020
1,69x
EV / Sales 2021
1,57x
Nbr of Employees
11 200
Free-Float
99,2%
Perrigo Company plc develops, produces, and sells therapy and care products. Sales break down by product family as follows:
- consumable care products (80%). The group also offers medical diagnostic products. Net sales break down by geographical area between the United States/Canada/Mexico (64.3%), Europe and Australia (35,7%);
- generic prescription drugs (20%).
At the end of 2019, the group has 93 production...
Notations Surperformance© of Perrigo Company plc
Trading Rating : Investor Rating :
All news about PERRIGO COMPANY PLC
News in other languages on PERRIGO COMPANY PLC
Analyst Recommendations on PERRIGO COMPANY PLC
Chart PERRIGO COMPANY PLC
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends PERRIGO COMPANY PLC
Short Term Mid-Term Long Term Trends Bearish Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
11
Average target price
52,89 $
Last Close Price
43,42 $
Spread / Highest target
47,4%
Spread / Average Target
21,8%
Spread / Lowest Target
-7,88%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
